TIDMCTI

RNS Number : 9644P

Cathay International Holdings Ld

15 June 2020

The information contained within this announcement is considered by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No.596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information will be considered to be in the public domain.

Cathay International Holdings Limited

("Cathay" or the "Company")

Result of General Meeting ("GM")

Hong Kong, 15 June 2020 - Cathay International Holdings Limited (LSE: CTI.L), an operator and investor in the growing healthcare sector in the People ' s Republic of China , t oday announces that at the GM held earlier today, the Resolution as set out in the Notice of General Meeting dated 28 May 2020 was duly passed.

Pursuant to the Listing Rules, the date of transfer of listing category must not be less than 20 business days after the passing of the Resolution. The Board has applied for the transfer to be effected and, subject to the FCA confirming that the Company meets the eligibility requirements for such a listing, it is anticipated that the date of transfer will be 14 July 2020.

Final Poll Voting Result

The final poll voting result for the Resolution is shown in the table below. In accordance with the Listing Rules, only the votes attached to the listed Common Shares were counted for the purposes of voting on the Resolution.

 
 R esolution s               For             Against      Total           Abstain 
                                                           votes           / Withheld 
 1. SPECIAL RESOLUTION 
  Transfer from a Premium 
  Listing (commercial 
  company) to a Standard 
  Listing (shares) (Note 
  3)                         1,762,521,408   44,815,953   1,807,337,361   190 
 Condition (i)               1,762,521,408   44,815,953   1,807,337,361   190 
 Condition (ii)              386,580,571     44,815,953   431,396,524     190 
                            --------------  -----------  --------------  ------------

Notes:

1. A copy of the Resolution passed at the meeting is being uploaded today to the National Storage Mechanism and will shortly be available for viewing at www.morningstar.com.

   2.   The final voting result for the Resolution will also be displayed on the Company website at www.cathay-intl.com.hk

3. In accordance with the UK Listing Rules , the Proposed Transfer requires the Company to obtain the prior approval of a resolution for such transfer from: (i) not less than 75 per cent. of the votes attaching to the Common Shares voted on the resolution; and (ii) a simple majority of the votes attaching to the Common Shares of independent shareholders (being all Common Shareholders other than the Controlling Shareholder) voted on the resolution.

4. Any proxy votes which are at the discretion of the Chairman have been included in the 'For' total.

5. A vote 'Withheld' is not a vote in law and is not counted in the calculation of the proportion of the votes for and against the Resolutions.

- ENDS -

For further enquiries, please contact:

 
 Cathay International Holdings Limited 
  Eric Siu (Finance Director)                  Tel: +852 2828 9289 
  Patrick Sung (Director and Controller) 
 SPARK Advisory Partners Limited (sponsor) 
  Andrew Emmott                                Tel: +44 (0) 20 3368 
  James Keeshan                                3555

About Cathay

Cathay International Holdings Limited (LSE: CTI.L) is a main market listed investment holding company and an operator and investor in the healthcare sector in the People's Republic of China (the "PRC"). The Company and its subsidiaries (collectively the "Group") aim to leverage on investment opportunities in the growing domestic demand for high quality healthcare products in the PRC and build portfolio companies into market sector leaders with competitive edge. Cathay has already demonstrated a track record of identifying investment opportunities in this area including: Lansen, a leading specialty pharmaceutical company focused on rheumatology and dermatology in the PRC; Haizi, a company engaged in the manufacture, marketing and sale of inositol and its by-product, di-calcium phosphate; Natural Dailyhealth, a company engaged in production and sales of plant extracts for use as key active ingredients in healthcare products; and Botai, a company engaged in collagen products.

The Group employs approximately 1,300 people across the PRC, including over 20 specialist corporate and business development staff based at the holding company's offices in Hong Kong and Shenzhen. Cathay also has a hotel investment. For more information please visit the Company's website: www.cathay-intl.com.hk .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

ROMEANKSFDEEEEA

(END) Dow Jones Newswires

June 15, 2020 05:32 ET (09:32 GMT)

Cathay International Hol... (LSE:CTI)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024 Click aqui para mais gráficos Cathay International Hol....
Cathay International Hol... (LSE:CTI)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024 Click aqui para mais gráficos Cathay International Hol....